Pharmacokinetics and radiosensitizing effect of PR-350

Radiation Medicine - Medical Imaging and Radiation Oncology

Volumn 15, Issue 1, 1997, Pages 45-49

  Hirokawa, K ^a   Nakajima, T ^a   Tsumura, M ^a   Nishita, T ^a   Yamada, R ^a   Onoyama, Y ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

pharmacokinetics; PR 350; radiosensitizer; SR 2508

Indexed keywords

DORANIDAZOLE; ETANIDAZOLE; PR 28; RADIOSENSITIZING AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER RADIOTHERAPY; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG BRAIN LEVEL; DRUG EFFICACY; DRUG TUMOR LEVEL; MALE; MOUSE; NONHUMAN; RADIATION DOSE; RADIOSENSITIZATION;

ANIMALS; BRAIN; CARCINOMA, SQUAMOUS CELL; DOSE-RESPONSE RELATIONSHIP, RADIATION; IMIDAZOLES; MALE; MICE; MICE, INBRED C3H; NEOPLASM TRANSPLANTATION; RADIATION-SENSITIZING AGENTS;

EID: 0030959915     PISSN: 02882043     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)